Back to search

Article

Pharmacological correction of CFTR improves systemic inflammation and lung disease in Cystic Fibrosis but does not correct a basic defect in lung repair

2026-03-13

Abstract excerpt

<h4>Background</h4> Cystic Fibrosis (CF) is a lethal genetic condition affecting over 100,000 people worldwide, characterised by multi-organ dysfunction and a progressive lethal lung disease. The disease occurs due to faulty cystic fibrosis transmembrane conductance regulator (CFTR) ion channels effecting flow of chloride, bicarbonate and water out of cells. This causes thick mucus with repeated bacterial infecti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
308c26ab-1d47-5c04-9b49-811376935d79
DOI
10.64898/2026.03.11.26348124
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pharmacological correction of CFTR improves systemic inflammation and lung disease in Cystic Fibrosis but does not correct a basic defect in lung repairDOI 10.64898/2026.03.11.26348124
Select a neighboring publication to make it the new centre.